MaxCyte
MaxCyte is a clinical-stage global cell-based therapies and life sciences company applying its proprietary cell engineering platform to deliver the advances of cell-based medicine to patients with high unmet medical needs.
Last updated on
About MaxCyte
Founded
1999Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$77MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
GaithersburgState
MarylandCountry
United StatesTech Stack (90)
